Entecavir
Inquiry
| Post Date: | Feb 04,2015 |
| Expiry Date: | Feb 04,2016 |
| Detailed Description: |
Cas No. :142217-69-4
Product name: Entecavir
CAS: 142217-69-4 Molecular formula: C12H15N5O3 Molecular weight: 277.283 Description: Entecavir, abbreviated ETV, is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade names Baraclude (BMS), Entaco (Ranbaxy) and Entaliv (DRL). Entecavir is a nucleoside analog[1] (more specifically, a guanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. The drug's manufacturer claims that entecavir is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). Entecavir was approved by the U.S.FDA in March 2005. |
| CAS Registry Number: | 142217-69-4 |
| Synonyms: | ;2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one;2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one;2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one hydrate (1:1);entecavir Baraclude; |
| Molecular Formula: | C12H15N5O3 |
| Molecular Weight: | 277.2792 |
| Molecular Structure: | 
|
| Company: | AUSMAUCO BIOTECH CO., LIMITED [ China ] |
| Contact: | john |
| Tel: | +8618060810639 |
| Fax: | |
| Email: | plantsale@aus-bio.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
